X0306 4 2015-06-16 0 0001269021 PORTOLA PHARMACEUTICALS INC PTLA 0001644888 Fu Tao C/O PORTOLA PHARMACEUTICALS, INC. 270 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 0 1 0 0 EVP, CBO Common Stock 2015-06-15 4 A 0 2500 0.00 A 2500 D Stock Option (Right to Buy) 44.39 2015-06-15 4 A 0 140000 0.00 A 2025-06-15 Common Stock 140000 140000 D Performance Stock Unit 2015-06-15 4 A 0 25000 0.00 A 2019-01-15 Common Stock 25000 25000 D Grant of Restricted Stock Units ("RSU") in consideration of services rendered. The RSU's will vest in three equal tranches on March 1, 2016, March 1, 2017, and March 1, 2018, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2013 Equity Incentive Plan) as of each such date. The option shares shall be subject to a four (4) year vesting schedule, such that 1/4th of the shares subject to such option shall vest on the one (1) year anniversary of the grant date, thereafter, 1/48th of the shares subject to such option shall vest each month for thirty-six (36) months, subject to Reporting Person's Continuous Service as of each such date. Each Performance Stock Unit ("PSU") represents a contingent right to receive one (1) share of Issuer's Common Stock. The PSU's vest as follow: 5,000 shares subject to each PSU will be earned when the average closing price of Issuer's Common Stock on the NASDAQ Global Select Market is above $50.00 per share over a period of forty-five (45) consecutive trading days, and an additional 20,000 shares will be earned when the average closing price of Issuer's Common Stock is above $60.00 per share over a period of forty-five (45) consecutive trading days. Any shares earned will then vest on the one (1) year anniversary of the date such shares were earned, subject to Reporting Person's Continuous Service as of each such date. /s/ Mike Ouimette, as attorney-in-fact 2015-06-17